Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

3,650.00p
   
  • Change Today:
    250.00p
  • 52 Week High: 5,060.00p
  • 52 Week Low: 3,225.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 9,717
  • Market Cap: £190.52m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

1 Day Chart (31-10-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.2% 0.0%
Div Cover 1.0 n/a
Op Mrgn 77.8% n/a
ROCE 75.6%  
Latest F'cast
P/E 23.5 n/a
PEG n/a n/a
Pr/Revenue 14.0 n/a
Pr/Book 15.9  
Latest F'cast
Revenue 6.2% n/a
PBT 4.6% n/a
EPS -3.4% n/a
DPS 2.0% n/a

Bioventix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 10.31 8.23 139.41p 29.8 1.4 +22% 88.00p 2.1%
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%
30-Jun-24 13.61 10.60 155.12p 28.4 n/a -3% 155.00p 3.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Bioventix Forecasts

Bioventix Forecasts data is not available for this company.

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Director/PDMR Shareholding 31-Oct-2024 07:00 RNS
Results for the year ended 30 June 2024 28-Oct-2024 07:00 RNS
Holding(s) in Company 25-Oct-2024 10:37 RNS

Latest Bioventix Director Deals

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 3,650.00p
Change Today 250.00p
% Change 7.35 %
52 Week High 5,060.00p
52 Week Low 3,225.00p
Volume 9,717
Shares Issued 5.22m
Market Cap £190.52m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.84% below the market average27.84% below the market average27.84% below the market average27.84% below the market average27.84% below the market average
8% below the sector average8% below the sector average8% below the sector average8% below the sector average8% below the sector average
Price Trend
20.43% below the market average20.43% below the market average20.43% below the market average20.43% below the market average20.43% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Income Not Available
Growth
41.91% below the market average41.91% below the market average41.91% below the market average41.91% below the market average41.91% below the market average
5.88% below the sector average5.88% below the sector average5.88% below the sector average5.88% below the sector average5.88% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 07-Nov-24 11-Apr-24
Paid 21-Nov-24 26-Apr-24
Amount 87.00p 68.00p

Trades for 31-Oct-2024

Time Volume / Share Price
16:45 472 @ 3,600.00p
15:42 1,000 @ 3,650.00p
16:26 12 @ 3,665.00p
16:05 31 @ 3,626.00p
14:59 1,000 @ 3,562.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page